These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 7672817)
1. Natural selection on the peptide-binding regions of major histocompatibility complex molecules. Hughes AL; Hughes MK Immunogenetics; 1995; 42(4):233-43. PubMed ID: 7672817 [No Abstract] [Full Text] [Related]
2. Natural selection at major histocompatibility complex loci of vertebrates. Hughes AL; Yeager M Annu Rev Genet; 1998; 32():415-35. PubMed ID: 9928486 [TBL] [Abstract][Full Text] [Related]
3. Immunogenetics of reproduction: an overview. Ober C; van der Ven K Curr Top Microbiol Immunol; 1997; 222():1-23. PubMed ID: 9257483 [No Abstract] [Full Text] [Related]
4. A genomic perspective on HLA evolution. Meyer D; C Aguiar VR; Bitarello BD; C Brandt DY; Nunes K Immunogenetics; 2018 Jan; 70(1):5-27. PubMed ID: 28687858 [TBL] [Abstract][Full Text] [Related]
5. Highly conserved, potential cleavage sites about the desetopes of MHC class I and class II molecules. Lam V; Thomas LJ; Kostyal DA; Humphreys RE Tissue Antigens; 1992 Jan; 39(1):26-31. PubMed ID: 1542874 [No Abstract] [Full Text] [Related]
6. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Hattotuwagama CK; Doytchinova IA; Flower DR Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004 [TBL] [Abstract][Full Text] [Related]
7. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. Reche PA; Reinherz EL J Mol Biol; 2003 Aug; 331(3):623-41. PubMed ID: 12899833 [TBL] [Abstract][Full Text] [Related]
8. [Human histocompatibility HLA system. Considerations in the light of current concepts. VIII. Polymorphism of HLA-related MIC system]. Kedzierska A; Turowski G Przegl Lek; 2001; 58(12):1076-8. PubMed ID: 12041026 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of major-histocompatibility-complex-linked genes affecting reproduction. Gill TJ Am J Reprod Immunol; 1999 Jan; 41(1):23-33. PubMed ID: 10097784 [TBL] [Abstract][Full Text] [Related]
10. [Non-classical human leukocyte antigen (HLA) tissue types--from implantation to transplantation]. Hviid TV Ugeskr Laeger; 2006 Jan; 168(5):461-6. PubMed ID: 16472433 [TBL] [Abstract][Full Text] [Related]
11. Immunogenetics of HLA. Bach FH Wien Klin Wochenschr; 1991; 103(5):141-5. PubMed ID: 2031350 [TBL] [Abstract][Full Text] [Related]
12. Polymorphism and evolution of HLA class I and II genes and molecules. Little AM; Parham P Rev Immunogenet; 1999; 1(1):105-23. PubMed ID: 11256568 [TBL] [Abstract][Full Text] [Related]
13. Main histocompatibility complex and reproductive system. Kurpisz M; Fernandez N Am J Reprod Immunol; 1992 Aug; 28(1):19-30. PubMed ID: 1418412 [No Abstract] [Full Text] [Related]
14. Nomenclature and serology of HLA class I and class II alleles. McCluskey J; Kanaan C; Diviney M Curr Protoc Immunol; 2003 Feb; Appendix 1():Appendix 1S. PubMed ID: 18432895 [TBL] [Abstract][Full Text] [Related]
16. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. Vigna JL; Smith KD; Lutz CT J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053 [TBL] [Abstract][Full Text] [Related]
19. Regulation of expression of MHC gene products: evidence from HLA variants. Pious D; Gladstone P Transplant Proc; 1981 Dec; 13(4):1800-3. PubMed ID: 6949384 [No Abstract] [Full Text] [Related]
20. Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers. Le YS; Kim TE; Kim BK; Park YG; Kim GM; Jee SB; Ryu KS; Kim IK; Kim JW Exp Mol Med; 2002 Mar; 34(1):18-26. PubMed ID: 11989974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]